Ciro Pharma invests Rs 800 crore in India’s first integrated oncology manufacturing facility in Hyderabad
Ciro Pharma has opened an Rs 800 crore integrated oncology manufacturing facility at Genome Valley, creating 500 direct jobs in the first phase.
Ciro Pharma has opened what it describes as India’s first integrated oncology manufacturing facility, at Biotech Park Phase III in Genome Valley, Hyderabad. The company has invested Rs 800 crore in the plant, which was inaugurated by Sri D. Sridhar Babu, Minister for IT, Electronics & Communications, Industries & Commerce and Legislative Affairs.
The facility will make oral oncology medicines, sterile injectables, lyophilised powder injections and soft gel capsules, using advanced containment technology suited to cancer therapies.
The unit will create 500 direct jobs in the first phase, and employment is expected to double in the coming years. The investment further strengthens Telangana’s role as a global hub for life sciences and pharmaceutical manufacturing.